"Formerly Asheville Hematology & Oncology - Asheville"

During the past decade, AdventHealth Infusion Center Asheville conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 15 clinical trials were completed, i.e. on average, 34.1% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 13 clinical trials were completed. i.e. 108.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AdventHealth Infusion Center Asheville" #1 sponsor was "National Cancer Institute (NCI)" with 32 trials, followed by "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "NRG Oncology" with 4 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AdventHealth Infusion Center Asheville" #1 collaborator was "National Cancer Institute (NCI)" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Brain Science Foundation" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "AdventHealth Infusion Center Asheville" are "Recurrent Breast Carcinoma" (4 trials), "Colon Adenocarcinoma" (3 trials), "Fallopian Tube Transitional Cell Carcinoma" (3 trials), "Ovarian Transitional Cell Carcinoma" (3 trials) and "Recurrent Melanoma" (3 trials). Many other conditions were trialed in "AdventHealth Infusion Center Asheville" in a lesser frequency.

Most popular intervention types in "AdventHealth Infusion Center Asheville" are "Drug" (45 trials), "Other" (44 trials), "Biological" (24 trials), "Procedure" (19 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Quality-of-Life Assessment" (18 trials), "Computed Tomography" (11 trials), "Nivolumab" (10 trials) and "Biospecimen Collection" (9 trials). Other intervention names were less common.

The vast majority of trials in "AdventHealth Infusion Center Asheville" are 47 trials for "All" genders and 12 trials for "Female" genders.

Currently, there are NaN active trials in "AdventHealth Infusion Center Asheville". undefined are not yet recruiting, 15 are recruiting, 36 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in AdventHealth Infusion Center Asheville, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in AdventHealth Infusion Center Asheville, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".